Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 3/20 | 0.93 |
| ▸ | S100A4 | P26447 | 2/20 | 0.93 |
| ▸ | BCHE | P06276 | 1/20 | 0.93 |
| ▸ | ACHE | P22303 | 1/20 | 0.93 |
| ▸ | CES1 | P23141 | 1/20 | 0.93 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | STAT6 | P42226 | 1/20 | 0.65 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 4/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31615476 | 1.00 | PTPRC (0.93) | PTPRCS100A4BCHEACHECES1 | |
| SCHEMBL5156700 | 0.98 | PTPRC (0.89) | PTPRCS100A4BCHEACHECES1 | |
| SCHEMBL2599395 | 0.96 | PTPRC (1.00) | PTPRCS100A4BCHEACHECES1 | |
| SCHEMBL8668444 | 0.96 | PTPRC (0.93) | PTPRCS100A4BCHEACHECES1 | |
| SCHEMBL30096355 | 0.96 | PTPRC (1.00) | PTPRCS100A4BCHEACHECES1 | |
| SCHEMBL6940816 | 0.92 | PTPRC (1.00) | PTPRCS100A4BCHEACHECES1 | |
| SCHEMBL8104719 | 0.92 | PTPRC (0.84) | PTPRCS100A4BCHEACHECES1 | |
| SCHEMBL30375977 | 0.92 | PTPRC (0.84) | PTPRCS100A4BCHEACHECES1 | |
| SCHEMBL2772220 | 0.92 | PTPRC (0.83) | PTPRCS100A4BCHEACHECES1 | |
| SCHEMBL11207794 | 0.92 | PTPRC (0.83) | PTPRCS100A4BCHEACHECES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 376 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021107404-A1 | POLARIZER, POLARIZER MANUFACTURING METHOD, AND DISPLAY DEVICE HAVING SAME | 엘지디스플레이 주식회사 | 2021-06-03 | — | — | WO | claimed |
| CN-111885914-A | Compositions and methods for producing expanded hematopoietic stem cells using fluorene derivatives | 投资健康有限责任公司 | 2020-11-03 | — | — | CN | claimed |
| EP-3700334-A1 | COMPOSITIONS AND METHODS OF MAKING EXPANDED HEMATOPOIETIC STEM CELLS USING DERIVATIVES OF FLUORENE | Transfusion Health, LLC (US) | 2020-09-02 | — | — | EP | claimed |
| US-20200255371-A1 | COMPOSITIONS AND METHODS OF MAKING EXPANDED HEMATOPOIETIC STEM CELLS USING DERIVATIVES OF FLUORENE | IMMUNEBRIDGE LLC | 2020-08-13 | — | — | US | claimed |
| US-20110262845-A1 | METHOD FOR MODULATING LIGHT OF PHOTOREFRACTIVE COMPOSITION WITHOUT EXTERNAL BIAS VOLTAGE | NITTO DENKO CORPORATION | 2011-10-27 | — | — | US | claimed |
| US-7732534-B2 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2010-06-08 | — | — | US | claimed |
| WO-2010047904-A1 | METHOD FOR MODULATING LIGHT OF PHOTORE-FRACTIVE COMPOSITION WITHOUT EXTERNAL BIAS VOLTAGE | NITTO DENKO CORPORATION (JP) | 2010-04-29 | — | — | WO | claimed |
| CN-100422128-C | Oxidation preparation method for 9- fluorenone compound from fluorine compound | UNIV SHANXI (CN) | 2008-10-01 | — | — | CN | claimed |
| US-20080051552-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION | 2008-02-28 | — | — | US | claimed |
| US-20080051519-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2008-02-28 | — | — | US | claimed |
| CN-1962597-A | Oxidation preparation method for 9- fluorenone compound from fluorine compound | UNIV SHANXI (CN) | 2007-05-16 | — | — | CN | claimed |
| EP-1172700-A2 | Photoconductive imaging members | Xerox Corporation (US) | 2002-01-16 | — | — | EP | claimed |
| US-6194110-B1 | Imaging members | XEROX CORPORATION | 2001-02-27 | — | — | US | claimed |
| JP-59000157-A | — | — | None | — | — | JP | disclosed |
| CN-122095297-A | Composition for forming cured film, alignment material, and phase difference material | — | 2026-05-26 | — | — | CN | disclosed |
| US-12637600-B2 | Photocurable composition, cured product of same, photofusible resin composition and adhesive set | RESONAC CORPORATION (JP) | 2026-05-26 | — | — | US | disclosed |
| US-4242260-A | ELECTROGRAPHY; PHOTOCONDUCTIVITY | RICOH COMPANY, LTD. (JP) | 1980-12-30 | — | — | US | disclosed |
| US-4229511-A | Electrophotography with uniform exposure for residual potential | RICOH COMPANY, LTD. (JP) | 1980-10-21 | — | — | US | disclosed |
| US-3994724-A | SUBSTITUTED ANILINE PHOTOCONDUCTOR | SCOTT PAPER COMPANY (US) | 1976-11-30 | — | — | US | disclosed |
| US-3939276-A | ANTHRAQUINONES, ASTHMA, ANTIALLERGENS | BURROUGHS WELLCOME CO. (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637600-B2 | Photocurable composition, cured product of same, photofusible resin composition and adhesive set | ESD, CDH1, ASH2L | PTPRC 4805/4885S100A4 3052/4885BCHE 3677/4885 |
| US-20200255371-A1 | COMPOSITIONS AND METHODS OF MAKING EXPANDED HEMATOPOIETIC STEM CELLS USING DERIVATIVES OF FLUORENE | FLI1, MCL1, HCLS1 | PTPRC 1353/4885S100A4 514/4885BCHE 3416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.